Gynaecomastia Associated with Saquinavir Therapy

Gynaecomastia has been reported in an HIV-1-infected man treated with a triple antiviral regimen including indinavir. We describe 4 cases of men with gynaecomastia associated with saquinavir (hard gel capsule) therapy who denied taking any hormonal supplements or opiates.

Saved in:
Bibliographic Details
Published inInternational journal of STD & AIDS Vol. 10; no. 1; pp. 49 - 50
Main Authors Donovan, Basil, Bodsworth, Neil J, Mulhall, Brian P, Allen, Debbie
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.01.1999
Royal Society of Medicine Press
Sage Publications Ltd
Subjects
Adult
Anti-HIV Agents - adverse effects
Anti-HIV Agents - therapeutic use
Biological and medical sciences
Drug toxicity and drugs side effects treatment
Gynecomastia - chemically induced
HIV Infections - complications
HIV Infections - drug therapy
HIV Protease Inhibitors - adverse effects
HIV Protease Inhibitors - therapeutic use
HIV-1
Humans
Male
Medical sciences
Middle Aged
Miscellaneous (drug allergy, mutagens, teratogens...)
Pharmacology. Drug treatments
Saquinavir - adverse effects
Saquinavir - therapeutic use
Gynaecomastia
protease inhibitor
HIV infection
lipodystrophy
saquinavir
Human
Immunopathology
Toxicity
Male
AIDS
Gynecomasty
Immune deficiency
Infection
Case study
Mammary gland diseases
Saquinavir
Treatment
Viral disease
Antiviral
Online AccessGet full text

Cover

More Information
Summary:Gynaecomastia has been reported in an HIV-1-infected man treated with a triple antiviral regimen including indinavir. We describe 4 cases of men with gynaecomastia associated with saquinavir (hard gel capsule) therapy who denied taking any hormonal supplements or opiates.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0956-4624
1758-1052
DOI:10.1258/0956462991912935